Briggs, Andrew; Fenn, Paul - In: Health Economics 7 (1998) 8, pp. 723-740
Although cost-effectiveness analysis is not new, it is only recently that economic analysis has been conducted alongside clinical trials. Whereas in the past economic analysts most often used sensitivity analysis to examine the implications of uncertainty for their results, the existence of...